Howe & Rusling’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
DCM
Howe & Rusling's ACLS Position: Q4 2022 in Review
Howe & Rusling sold out of Axcelis (ACLS) in Q4 2022, closing a stake of 69 shares — an estimated $4K sold.
Howe & Rusling first reported a position in ACLS in Q1 2021 and held it in 7 quarters. The position peaked at $7K in Q4 2021. 325 funds tracked by Wall St. Rank hold ACLS as of Q4 2022.
- Howe & Rusling reported no remaining Axcelis position as of Q4 2022 after selling out during the quarter.
- Howe & Rusling sold 69 Axcelis shares in Q4 2022, an estimated $4K.
- Howe & Rusling first reported a position in Axcelis in Q1 2021 and held it in 7 quarters.
- Howe & Rusling's Axcelis position peaked at $7K in Q4 2021.
- 325 funds tracked by Wall St. Rank held Axcelis as of Q4 2022.
Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.